Funding News

DENVER--(BUSINESS WIRE)--Lumen Technologies, Inc. (“Lumen,” “us,” “we” or “our”) (NYSE: LUMN) today announced that its wholly-owned subsidiary, Level 3 Financing, Inc. (“Level 3 Financing”), plans to offer $1 billion aggregate principal amount of its Senior Notes due 2037 (the “Notes”) and together with Lumen and Qwest Capital Funding, Inc. (“QCF,” together with Level 3 Financing and Lumen, each an “Offeror”, and collectively, the “Offerors”), Lumen’s indirect and wholly-owned subsidiary, comme...

SAN JOSE, Calif.--(BUSINESS WIRE)--Tessera Labs to accelerate enterprise transformation with $60M funding led by Andreessen Horowitz...

NEW YORK--(BUSINESS WIRE)--Accenture has made a strategic investment in XBOW, a leading autonomous cybersecurity testing platform powered by agentic AI....

SAN FRANCISCO--(BUSINESS WIRE)--Astranis today announced it has raised $450 million in new capital, bringing the company’s total raised to more than $1.2 billion as it scales to meet increased demand for its spacecraft designed for geostationary orbit (GEO) and other high orbits. The funding includes a new $300 million Series E round co-led by Snowpoint Ventures and Franklin Templeton, with participation from Andreessen Horowitz, funds and accounts managed by affiliates of BlackRock, Baillie Gi...

PRINCETON, N.J.--(BUSINESS WIRE)--Kanvas Biosciences, a full-stack spatial biology company, today announced it has raised a $48 million Series A funding round co-led by existing investors DCVC and Lions Capital LLC. Additional participating investors include Gates Foundation, ATHOS KG, Germin8, Ki Tua Fund, Pangaea Ventures and more. The fresh capital follows a July 2024 round and brings Kanvas’ total funding to $78 million. The funding will be used to conduct clinical trials for the lead drug...

FRANKLIN, Tenn.--(BUSINESS WIRE)--Community Health Systems, Inc. (the “Company”) (NYSE: CYH) today announced certain matters with respect to its cash tender offer previously announced on April 22, 2026 (as it may be amended from time to time, the “Tender Offer”) by its wholly owned subsidiary, CHS/Community Health Systems, Inc. (the “Issuer”), to purchase for cash up to $600,000,000 aggregate purchase price (exclusive of accrued and unpaid interest, the “Aggregate Maximum Purchase Amount”) of (...

WACO, Texas--(BUSINESS WIRE)--BlackRock today announced a $30 million philanthropic investment in Texas through BlackRock Future Builders, a national initiative funded by The BlackRock Foundation to strengthen skilled trades pipelines across the United States. Over three years, funding from the grants will be used to help train more than 12,000 Texans for electrical careers, strengthening the workforce needed to support Texas’ rapid growth. The launch will be highlighted on National Skilled Tra...

LOS ANGELES--(BUSINESS WIRE)--District, an AI commerce platform, today announced $14.7M in seed funding led by Andreessen Horowitz and Kindred Ventures, with participation from Greylock Partners, Jaren Glover, former Depop CEO Maria Raga, Gokul Rajaram, Soleio, Deborah Liu, Imran Khan, Jacob Andreou, Peter Sellis, Josh Siegel, SV Angel, 20VC, and others. Founded by Snap alumni Eddie Koai, Patrick Mandia, and Khoi Tran, District is an AI-powered commerce platform designed to help anyone build an...

SEATTLE--(BUSINESS WIRE)--XBOW, the leader in autonomous offensive security, today announced $35 million in additional Series C financing from investors Accenture Ventures, DNX Ventures, Liberty Global Tech Ventures, NVentures (NVIDIA’s venture capital arm), Samsung Ventures, and SentinelOne S Ventures. The raise extends its previously announced $120 million Series C round, and highlights a broader shift: major enterprises are not just adopting XBOW’s platform, but investing in it as they look...

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--CellCentric, a clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma, today announced the completion of an oversubscribed $220 million Series D financing. The financing was led by specialist investor Venrock Healthcare Capital Partners, with participation from a strong syndicate of new and existing investors. Proceeds will support the advancement of inobrodib thro...